News Copaxone first on FDA's list for faster complex generic appr... Teva will attempt to block generic launch in courts
Views & Analysis Neurotechnology for tailored patient care Advanced implantable medical devices could treat hundreds of chronic conditions in the future.
News FDA names MDMA a 'breakthrough' for post-traumatic stress US non-profit organisation to begin late-stage trials this year
News AZ to develop Parkinson's drug with Takeda AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
